MedPath

To evaluate comparatively the use of aamra pallava yoga in the management of Garbhini Chardi w.s.r emesis gravidarum

Not yet recruiting
Conditions
Mild hyperemesis gravidarum. Ayurveda Condition: GARBINIROGAH,
Registration Number
CTRI/2025/03/083091
Lead Sponsor
Dr Sahil Sanjay Jadhav
Brief Summary

The present title ’A comparative clinical study to evaluate the efficacy of amrapallava Yoga In The Management Of Garbhini Chardi w.s.r emesis gravidarum ’ A clinical study of 60 registered pregnant women with their inclusion criteria and randomly alloted into 2 groups in each 30.

Group A will be administered with amrapallava Yoga 100mg BD with water

Group B will be administered with Tab Doxylamine succinate 10 mg 2 Hs.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients between ahe of 20-35 yrs age Patient diagnosed as Garbhini chardi in first trimester of pregnancy Both primi and multiparae.

Exclusion Criteria
  • Patients with hyper emesis gravidarum.
  • Patients in whom chardi seen in second and third trimester.
  • Patients with twin pregnancy, vesicular mole and ectopic pregnancy.
  • Vomiting caused due to systemic disorders like peptic ulcer, renal calculi, and appendicitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Amra pallava yoga in Garbhini chardi45 days or upto first trimester
Secondary Outcome Measures
NameTimeMethod
To study in detail about garbhini chardi.To study in detail about Emesis Gravidarum.

Trial Locations

Locations (1)

Dr.N.A.Magdum hospital Striroga and Prasuti Tantra department OPD no 1 Ankli

🇮🇳

Belgaum, KARNATAKA, India

Dr.N.A.Magdum hospital Striroga and Prasuti Tantra department OPD no 1 Ankli
🇮🇳Belgaum, KARNATAKA, India
DrSahil Sanjay Jadhav
Principal investigator
9021434606
sahilsj298@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.